Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report

RATIONALE: Poorly differentiated neuroendocrine carcinoma of the breast is a rare cancer with poor prognosis. There is no standard treatment for the disease. Neoadjuvant therapies and surgery are considered to be the main treatment when the tumor diameter is greater than 5.0 cm. Neoadjuvant therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yonglin, Liu, Chao, Zheng, Chaoting, Ren, Qiaozhen, Wang, Qimin, Gao, Xinyi, He, Yushuang, Wu, Jierong, Chen, Guanglei, Li, Xuelu, Ma, Zhenhai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581040/
https://www.ncbi.nlm.nih.gov/pubmed/33120755
http://dx.doi.org/10.1097/MD.0000000000022652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581040/
https://www.ncbi.nlm.nih.gov/pubmed/33120755
http://dx.doi.org/10.1097/MD.0000000000022652

Ejemplares similares